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Abstract
Background  and  objectives:  Hemodynamic  response  to  airway  stimuli  is  a  common  phenomenon
and its  management  is  important  to  reduce  the  systemic  repercussions.  The  objective  of  this
study is  to  compare  the  efﬁcacy  of  intravenous  magnesium  sulfate  versus  lidocaine  on  this  reﬂex
hemodynamics  after  laryngoscopy  and  tracheal  intubation.
Methods:  This  single-center,  prospective,  double-blind,  randomized  study  evaluated  56  patients
ASA 1  or  2,  aged  18--65  years,  scheduled  for  elective  surgeries  under  general  anesthesia  with
intubation.  The  patients  were  allocated  into  two  groups:  Group  F  received  30  mg·kg−1 of  mag-
nesium sulphate  and  Group  L,  2  mg·kg−1 of  lidocaine,  continuous  infusion,  immediately  before
the anesthetic  induction.  Blood  pressure  (BP),  heart  rate  (HR),  and  bispectral  index  (BIS)  were
measured  in  both  groups  at  six  different  times  related  to  administration  of  the  study  drugs.
Results: In  both  groups  there  was  an  increase  in  HR  and  BP  after  laryngoscopy  and  intubation,
compared  to  baseline.  Group  M  showed  statistically  signiﬁcant  increase  in  the  values  of  systolic
and diastolic  blood  pressure  after  intubation,  which  was  clinically  unimportant.  There  was  no
difference  in  the  BIS  values  between  groups.  Among  patients  receiving  magnesium  sulfate,  three
(12%) had  high  blood  pressure  versus  only  one  among  those  receiving  lidocaine  (4%),  with  no
statistical  difference.∗ Corresponding author.
E-mail: fabricio.tavares@me.com (F.T. Mendonc¸a).
ttp://dx.doi.org/10.1016/j.bjane.2015.08.004
104-0014/© 2016 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusion:  Magnesium  sulfate  and  lidocaine  have  good  efﬁcacy  and  safety  for  hemodynamic
management  in  laryngoscopy  and  intubation.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Os  efeitos  da  lidocaína  e  do  sulfato  de  magnésio  na  atenuac¸ão  da  resposta
hemodinâmica  à  intubac¸ão  orotraqueal:  estudo  unicêntrico,  prospectivo,
duplamente  encoberto  e  aleatorizado
Resumo
Justiﬁcativa  e  objetivos:  A  resposta  hemodinâmica  aos  estímulos  das  vias  aéreas  é  um  fenô-
meno comum  e  seu  controle  é  importante  para  diminuir  as  repercussões  sistêmicas.  O  objetivo
deste trabalho  é  comparar  os  efeitos  da  administrac¸ão  endovenosa  de  sulfato  de  magnésio
versus lidocaína  na  hemodinâmica  desse  reﬂexo  após  a  laringoscopia  e  intubac¸ão  orotraqueal.
Métodos:  Este  estudo  duplamente  encoberto,  aleatorizado,  unicêntrico  e  prospectivo  avaliou
56 pacientes,  ASA  1  ou  2,  entre  18  e  65  anos,  escalados  para  cirurgias  eletivas  sob  anestesia
geral com  intubac¸ão  orotraqueal.  Foram  alocados  em  dois  grupos,  o  M  recebeu  30  mg·kg−1
de  sulfato  de  magnésio  e  o  L,  2  mg·kg−1 de  lidocaína,  em  infusão  contínua,  imediatamente
antes da  induc¸ão  anestésica.  Os  valores  de  pressão  arterial  (PA),  frequência  cardíaca  (FC)  e
índice biespectral  (BIS)  foram  aferidos  nos  dois  grupos  em  seis  momentos  relacionados  com  a
administrac¸ão dos  fármacos  do  estudo.
Resultados:  Em  ambos  os  grupos  houve  aumento  na  FC  e  PA  após  a  laringoscopia  e  intubac¸ão,
em relac¸ão  aos  valores  basais.  No  Grupo  M  observou-se  elevac¸ão  estatisticamente  signiﬁcativa,
mas clinicamente  pouco  importante,  nos  valores  das  pressões  arteriais  sistólica  e  diastólica
após a  intubac¸ão.  Não  houve  diferenc¸a  nos  valores  de  BIS  entre  os  grupos.  Dos  pacientes  que
receberam  o  sulfato  de  magnésio,  3  (12%)  apresentaram  episódio  de  hipertensão,  ao  passo  que
apenas um  dos  que  receberam  lidocaína  (4%)  apresentou  esse  sinal,  sem  diferenc¸a  estatística.
Conclusão:  Sulfato  de  magnésio  e  a  lidocaína  apresentam  boa  eﬁcácia  e  seguranc¸a no  controle
hemodinâmico  à  laringoscopia  e  intubac¸ão.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
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Introduction
The  hemodynamic  response  to  stimuli  evoked  by  laryn-
goscopy  and  intubation  is  a  common  phenomenon,  resulting
from  the  release  of  endogenous  catecholamines  reﬂexively
to  the  upper  airway  afferents  when  stimulated.1 This  inap-
propriate  response  may  increase  perioperative  morbidity
and  mortality,  especially  in  patients  with  coexisting  dis-
ease,  particularly  patients  with  cardiovascular  disease.  The
management  of  this  defensive  reﬂex  is  essential  because
it  prevents  adverse  events,  such  as  tachycardia,  systemic
hypertension,  pulmonary  hypertension,  and  arrhythmias,
which  may  result  in  stroke  or  myocardial  infarction  resulting
from  hemodynamic  instability  produced  by  laryngoscopy  and
intubation.  Many  drugs  are  the  subject  of  studies,  including
those  with  good  results,  such  as  magnesium  sulfate1--3 and
lidocaine.4--6
The  magnesium  sulfate  mechanism  of  action  for  hemo-
dynamic  response  attenuation  appears  to  result  from
the  inhibition  of  catecholamine  release  from  the  adrenal
medulla,  maintains  the  plasma  concentration  of  epinephrine
practically  unchanged,  and  also  reduces  the  increased  cir-
culating  norepinephrine  when  compared  to  that  of  a  control
group.2 It  also  has  a  systemic  and  coronary  vasodilation
effect  by  antagonizing  calcium  ion  in  vascular  smooth
(
senc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
uscle.7 As  for  lidocaine,  when  used  systemically,  it  has  an
ntagonistic  action  on  sodium  channels  and  NMDA  receptors,
educes  the  release  of  substance  P,  has  glycinergic  action,
hich  decreases  the  airway  reactivity.8,9
The  aim  of  this  study  was  to  compare  the  effects  of  intra-
enous  magnesium  sulfate  with  lidocaine  on  hemodynamics
uring  intubation.
aterial and methods
his  prospective,  randomized,  double  blind,  single-center
tudy  was  approved  by  the  Research  Ethics  Committee  ----
EPECS/SES-DF  ----  under  the  opinion  number  799,112  on
eptember  22,  2014,  and  is  identiﬁed  in  the  Plataforma
rasil  (http://aplicacao.saude.gov.br/plataformabrasil)  as
AAE  No  33365114.7.0000.5553  and  registered  in  Clinical-
rials  (NCT02359370).  After  written  informed  consent  was
iven,  56  patients,  ASA  1  or  2,  aged  between  18--65  years,
cheduled  for  elective  surgery  with  orotracheal  intubation
OTI)  were  assessed  for  eligibility,  between  September  andFig.  1).
Patients  with  contraindications  or  history  of  hypersen-
itivity  to  the  study  drugs,  those  with  coronary  ischemic
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Follow-up
Analysis
Assessed for eligibility (n=56)
Excluded (n=0)
Analyzed (n=24)
Lost to follow-up (n=0)
Selected to receive lidocaine (n=27) 
♦ Received intervention (n=24) 
♦ Did not receive intervention (n=3) 
- 1 did not receive intravenous drug properly; 1
vomited during induction; 1 failure in the first
laryngoscopy
Lost to follow-up (n=0)
Selected to receive magnesium (n=29) 
♦ Received intervention (n=25)
♦ Did not receive intervention (n=4)
- 1 arrhythmia; 1 received intranasal epinephrine; 1
video-laryngoscope intubation; 1 did not receive
sevoflurane during evaluations
Analyzed (n=25)
Randomized (n=56)
Allocation
Enrollment
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2Figure  1  Flowch
isease,  atrioventricular  block  of  any  degree,  known  cardiac
rrhythmias,  heart  failure,  renal  failure  of  any  kind,  on  beta
lockers  or  calcium  channel  blockers,  expected  difﬁcult
ntubation,  and  BMI  ≥35  kg·m−2 were  excluded.  Patients  who
ad  undergone  neuraxial  block  before  the  anesthetic  induc-
ion,  who  refused  to  participate  after  informed  consent
resentation,  required  two  or  more  attempts  at  laryn-
oscopy  for  orotracheal  tube  placement,  as  well  as  those
ith  any  other  condition  that,  in  the  researchers’  opinion,
ould  pose  risks  to  the  patient  or  interfere  with  the  study
bjectives  were  also  excluded.
Of  the  56  patients  selected  for  the  study  according  to  the
nclusion  criteria,  seven  were  excluded  during  assessments
Fig.  1)  for  patients’  safety  reasons  or  issues  not  covered
y  the  Protocol.  Four  patients  from  Group  M  (magnesium
ulfate)  were  excluded  due  to  frequent  ventricular  extrasys-
oles,  introduction  of  nasal  swab  of  adrenaline  before  the
nd  of  the  assessments,  intubation  with  video-laryngoscope
nd  lack  of  sevoﬂurane  in  the  vaporizer  not  checked  dur-
ng  the  evaluations.  Three  patients  from  Group  L  (lidocaine)
ere  excluded  due  to  leakage  of  drugs  (loose  ﬁxation  of
enous  access),  another  due  to  vomiting  with  consequent
spiration  under  mask  ventilation,  and  another  for  intuba-
ion  failure  in  the  ﬁrst  laryngoscopy.Patients  who  met  the  inclusion  criteria  were  selected  and
eceived  an  identiﬁcation  number,  according  to  the  order
f  inclusion  in  the  study.  The  investigators  responsible  for
ssessing  the  study  period  were  blind  to  group  allocation.
L
t
o
rf  randomization.
atients  were  randomized  using  a  list  of  numbers  gener-
ted  in  random  order.  An  investigator  not  involved  with
ata  assessment  randomly  assigned  the  patients  to  one  of
wo  groups  using  sealed  envelopes  containing  a  numeric
equence  generated  in  random  order,  recorded  their  data  in
edical  charts,  prepared  the  infusion  pump  and  delivered
t  in  the  operating  room,  so  the  investigators  were  unaware
f  which  drug  is  used.
In  the  operating  room,  the  patient  was  ﬁrst  identiﬁed,
ollowed  by  standard  monitoring  with  electrocardiogram
ECG),  saturation  of  peripheral  oxygen  (SpO2),  noninvasive
lood  pressure  (NIBP),  and  bispectral  index  (BIS).  Venipunc-
ure  was  performed  at  the  discretion  of  the  anesthesiologist,
n  accordance  with  the  surgery/anesthesia  scheduled
admission  time).  Subsequently,  midazolam  0.05  mg·kg−1
as  used  as  premedication.  After  two  minutes  (time  2  post-
DZ),  infusion  with  the  study  drug  was  started  with  2%
idocaine  (2  mg·kg−1)  without  vasoconstrictor  (Xylestesin,
ristália®) or  magnesium  sulphate  (30  mg·kg−1),  both  diluted
n  15  mL  of  solution  and  infused  in  10  min  by  continuous
nfusion  pump  (CIP).  At  the  end  of  infusion  (CIP  end  time),
re-oxygenation  and  anesthetic  induction  with  intravenous
entanyl  2  mcg  kg−1 were  performed,  followed  by  propofol
 mg·kg−1 and  rocuronium  0.6  mg·kg−1 (post-induction  time).
aryngoscopy  was  performed  three  minutes  after  the  end  of
he  rocuronium  injection  and  if  the  BIS  value  was  equal  to
r  less  than  50  (post-OTI  time).  If  the  BIS  value  was  not
eached,  a  venous  increment  of  propofol  (1  mg·kg−1)  was
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administered.  After  orotracheal  intubation,  anesthesia  was
maintained  with  2%  inhaled  sevoﬂurane,  and  new  measure-
ments  were  taken  three  and  six  minutes  after  intubation
(3′ post-OTI  and  6′ post-OTI).  Hypertension  was  considered
when  the  BP  values  were  20%  above  baseline  values  or  SBP
>140  mmHg.  Hypotension  was  considered  when  BP  values
were  lower  than  20%  of  baseline  or  SBP  <  90  mmHg.  Tachycar-
dia  was  considered  when  HR  was  higher  than  20%  of  baseline
or  HR  >  100  bpm.  Bradycardia  was  considered  when  HR  val-
ues  were  lower  than  50  bpm.
The  primary  endpoint  was  to  determine  the  effects  of
lidocaine  and  magnesium  sulfate  (Group  L  vs.  Group  M)  on
SBP  immediately  after  intubation  (post-OTI).  The  secondary
endpoints  were  the  assessment  of  changes  in  SBP,  DBP,  HR,
and  BIS  before  and  after  the  administration  of  study  drugs,
its  changes  within  six  minutes  after  intubation,  as  well  the
identiﬁcation  of  adverse  events  with  the  use  of  both  tech-
niques.
Considering  the  primary  outcome  of  SBP  immediately
after  intubation  (post-OTI  PAS),  a  24%  variance  with  20%
effect  difference,  two-tailed  alpha  error  of  5%  and  power
of  80%,  the  calculated  sample  size  would  be  25  patients  in
each  group.
Statistical  analysis  was  performed  with  the  XLSTAT  soft-
ware  for  Excel.  Shapiro--Wilks  test  was  used  to  determine
the  normal  distribution  of  continuous  variables.  All  con-
tinuous  variables  were  expressed  as  mean  and  standard
deviation.  Categorical  variables  were  expressed  as  num-
ber  of  patients  or  percentage  (%).  Quantitative  variables
with  normal  distribution  were  assessed  using  the  Student’s
t-test  for  independent  samples;  variables  without  normal
distribution  were  assessed  using  the  Mann--Whitney  non-
parametric  U  test;  and  categorical  variables  using  the
chi-square  test  or  Fisher’s  exact  test,  as  appropriate.  A  p-
value  <0.05  was  considered  signiﬁcant.  Data  were  expressed
as  mean  ±  SD  (mean,  standard  deviation)  or  absolute
numbers.
n
p
Table  1  Demographic  and  clinical  data  of  patients.
Group  L  
Age  (years)  48.54  ±  12.28  
Weight (kg)  71.30  ±  14.48  
Height (cm)  164  ±  10  
BMI (kg  m−2)  26.47  ±  3.6  
Sex (n)  
Male 13  
Female 11  
Physical state  (n)  
ASA I  11  
ASA II  13  
SAH (n)  7  
Drugs used  (n)
Diuretics  (n)  4  
ARA 4  
ACE 3  
Values are expressed as mean ± DP and numbers; there was no statistica
arterial hypertension; ARA, angiotensin receptor antagonist; ACE, angiynamic  response  53
esults
here  was  no  statistical  difference  in  both  groups  regarding
ge,  sex,  weight,  height,  and  BMI,  as  well  as  physical
tatus  classiﬁcation  by  ASA.  The  drugs  taken  as  antihy-
ertensive  agents  by  the  study  patients  were  diuretics,
ngiotensin  receptor  blockers  (ARBs),  and  angiotensin-
onverting  enzyme  (ACE)  inhibitors,  with  no  statistical
ifference  in  the  number  of  hypertensive  patients  or  users
f  drugs  from  each  medication  class  (Table  1).
There  was  no  statistical  difference  between  groups  in  HR,
BP,  DBP  and  BIS  values  at  admission;  after  midazolam,  infu-
ion  pump,  and  induction  times.  There  was  an  increase  in
R,  SBP  and  DBP  in  both  groups  after  laryngoscopy  compared
o  baseline.  Group  M  had  a  statistically  signiﬁcant  increase  in
BP  (p  =  0.018)  and  DBP  (p  =  0.0467)  post-OTI  (Fig.  2),  but  of
ittle  clinical  importance.  There  were  higher  pressure  values
n  the  3rd  and  6th  minutes  post-OTI  in  Group  M,  but  with-
ut  statistical  signiﬁcance.  After  this  period,  both  groups
howed  a  gradual  reduction  in  blood  pressure  values.  There
as  a  trend  to  higher  HR  values  in  the  continuous  infusion
ost-pump  time  (CIP  end)  in  Group  M,  also  with  no  statis-
ical  difference.  There  was  no  statistical  difference  in  HR
alues  at  time  points  (Fig.  3).  There  was  an  increase  in  heart
ate  after  laryngoscopy  in  both  groups,  followed  by  gradual
ecline.  Regarding  BIS  values,  both  groups  showed  a  simi-
ar  gradual  decrease  trend  up  to  the  induction,  followed  by
n  increase  after  intubation,  without  statistical  difference
Fig.  4).
There  was  a  tendency  to  hypotension  in  Group  L,  deﬁned
s  a decrease  over  20%  of  the  baseline  SBP  or  SBP  <  90  mmHg,
ut  without  statistical  signiﬁcance  (p  =  0.062).  No  patient
eceived  atropine  or  ephedrine.  In  Group  M,  three  patients
12%)  had  episodes  of  hypertension  (increase  in  SBP  >20%
f  baseline)  compared  to  one  patient  (4%)  in  Group  L,  with
o  statistical  difference  between  groups.  In  Group  M,  seven
atients  (28%)  had  tachycardia  compared  to  three  patients
Group  M  p
43.32  ±  13.63  0.1651
71.08  ±  13.29  0.95
168  ±  9  0.1328
25.22  ±  3.69  0.2372
0.879
13
12
0.32
15
10
3  0.098
1  0.143
3  0.641
0  0.068
l difference between groups. BMI, body mass index; SAH, systemic
otensin converting enzyme inhibitor.
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Figure  2  Mean  systolic  blood  pressure  (SBP)  and  diastolic
blood pressure  (DBP)  values.  There  was  statistical  difference  in
the post-OTI  time  (*p  =  0.0180  for  SBP,  and  *p  =  0.0467  to  DBP).
MDZ, midazolam;  CIP,  continuous  infusion  pump;  Ind,  anesthetic
induction;  OTI,  orotracheal  intubation.
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Figure  3  Mean  heart  rate  values.  There  were  no  statistical
differences.  HR,  heart  rate;  MDZ,  midazolam;  CIP,  continuous
i
b
(
w
D
S
N
r
s
v
p
0
Ad
mi
ssi
on
 
2’ 
po
st-
MD
Z 
CIP
 en
d
po
st-
Ind
 
po
st-
OT
I 
3’ 
po
st-
OT
I 
6’ 
po
st-
OT
I
10
20
30
40
50
60
70
80
90
100
BIS-L BIS- M
Figure  4  Mean  bispectral  index  (BIS)  values;  there  was  no
statistical  difference.  MDZ,  midazolam;  CIP,  continuous  infusion
pump; Ind,  anesthetic  induction;  OTI,  orotracheal  intubation.
Table  2  Intraoperative  data.
Group  L  Group  M  p
(n =  24)  (n  =  25)
Ephedrine  (n)  0  0  1.0
Atropine  (n)  0  0  1.0
Hypotension  (n)  13  7  0.062
Hypertension  (n)  1  3  0.317
Tachycardia  (n)  3  7  0.178
Bradycardia  (n)  0  0  1.0
Data are expressed as number of patients. Group G, lidocaine;
G
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tnfusion  pump;  Ind,  anesthetic  induction;  OTI,  orotracheal  intu-
ation.
12%)  in  Group  L,  also  with  no  statistical  difference.  There
ere  no  episodes  of  bradycardia  in  both  groups  (Table  2).
iscussion
imilar  to  the  results  reported  by  Ramires  et  al.10 and
ooarei  et  al.7,  we  observed  a  tendency  to  increased  heart
ate  in  Group  M  at  the  end  of  magnesium  sulfate  infu-
ion,  which  can  be  physiologically  explained  by  the  direct
asodilator  effect  of  this  drug.2,7,10,11 Despite  its  vasodilator
roperties,  there  was  a  greater  tendency  to  hypotension  in
s
o
o
dGroup M, magnesium sulfate. There was no statistical difference
between groups.
roup  L,  but  without  statistical  signiﬁcance.  There  was  no
se  of  vasopressor  in  patients,  as  hypotension  was  observed
mmediately  before  laryngoscopy,  a  time  known  to  increase
asomotor  tone.
Airway  management  during  laryngoscopy  and  intuba-
ion  cause  physiological  changes  that  can  be  harmful  to  a
umber  of  patients.12 Pharynx,  larynx,  trachea,  and  carina
re  highly  innervated  by  sympathetic  and  parasympathetic
bers.  Defensive  reﬂex  responses  to  airway  manipulation
nclude  tachycardia,  bronchospasm,  increased  blood  pres-
ure  and  intracranial  pressure.  Studies  have  shown  that
aryngoscopy  causes  20  mmHg  increase  in  systolic  blood
ressure12--17 and  a  simple  tracheal  suction  causes  at  least  a
 mmHg  increase  in  intracranial  pressure.12,18,19
Lidocaine  and  magnesium  sulfate  are  widely  used  in  order
o  decrease  the  hemodynamic  response  to  airway  manage-
ent,  with  proven  effectiveness.1,3,7,10 Magnesium  sulfate
locks  the  release  of  catecholamines  from  adrenergic  nerve
erminals  and  adrenal  gland,1,7,10 has  cardioprotective  and
ntiarrhythmic  action,10,20 and  induces  coronary  and  sys-
emic  vasodilation  by  antagonizing  calcium  ion  in  vascular
mooth  muscle.1,7,10,21 Lidocaine  has  an  antagonistic  action
n  sodium  channels,  NMDA  receptors,  reduces  the  release
f  substance  P,  and  has  glycinergic  action,8,9 resulting  in
ecreased  airway  reactivity.4
emod
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1Effects  of  lidocaine  and  magnesium  sulfate  in  attenuating  h
In  a  similar  study  performed  by  Nooraei  et  al.,  the  authors
compared  the  effect  of  lidocaine  and  magnesium  sulfate
on  the  hemodynamic  variables  of  laryngoscopy  and  found
better  control  of  blood  pressure  values  with  magnesium  sul-
fate,  although  with  increased  HR.7
Puri  et  al.1 also  compared  the  effects  of  magnesium
sulfate  and  lidocaine  on  cardiovascular  response  to  intuba-
tion  in  coronary  artery  disease  patients  undergoing  CABG
and  found  better  attenuation  of  the  hemodynamic  varia-
bles  with  magnesium  sulfate.  The  hemodynamic  results  were
higher  cardiac  index,  minimum  increase  in  HR,  and  signiﬁ-
cant  reduction  in  systemic  vascular  resistance.  In  this  study,
the  authors  observed  that  three  patients  in  Group  L  showed
ST  segment  depression,  while  this  ﬁnding  was  not  observed
in  Group  M.
The  above  results  diverge  from  the  present  study  proba-
bly  due  to  the  difference  in  used  doses  of  the  drugs  studied.
Noorei  et  al.7 used  magnesium  sulfate  (60  mg·kg−1) and
lidocaine  (1.5  mg·kg−1)  and  Puri  et  al.1 used  magnesium
sulfate  (50  mg·kg−1)  and  lidocaine  (1  mg·kg−1).  We  used  mag-
nesium  sulfate  (30  mg·kg−1)  because,  according  to  Panda
et  al.,3 it  is  the  optimal  drug  dose  to  attenuate  the  hemo-
dynamic  response  to  intubation  in  hypertensive  patients.  In
this  study  doses  were  compared  at  30,  40,  and  50  mg·kg−1 of
magnesium  sulfate  and  1.5  mg·kg−1 of  lidocaine  and  it  was
concluded  that  magnesium  sulfate  maintains  better  stability
compared  to  the  pretreatment  with  lidocaine  and  that  the
use  of  doses  at  40  and  50  mg·kg−1 led  to  more  episodes  of
hypotension  requiring  intervention.3 Therefore,  our  choice
was  to  use  magnesium  sulfate  30  mg·kg−1,  in  order  to  avoid
complications  during  the  procedure.  The  dose  of  lidocaine
was  chosen  based  on  the  work  by  Vivancos  et  al.4
Our  study  was  performed  with  healthy  patients  scheduled
for  elective  surgeries.  Our  technique  of  anesthesia  induc-
tion  caused  some  degree  of  hypotension,  which  was  well
tolerated  in  this  population.  Therefore,  our  results  may  not
extend  to  emergency  surgery  or  elderly  patients  or  patients
ASA  3--4  in  which  the  hemodynamic  tolerance  may  be  poor.
Magnesium  may  cause  a  dose-dependent  potentiation  of
neuromuscular  blockers  (NB),  which  was  not  monitored  in
our  study.  So  one  should  be  cautious  when  using  MgSO4  with  a
non-depolarizing  NB,22 such  as  rocuronium,  for  short  surger-
ies  or  in  special  situations,  when  a  difﬁcult  mask  ventilation
or  intubation  is  expected.
Conclusion
Our  study  showed  that  lower  magnesium  sulfate  doses
are  sufﬁcient  to  attenuate  the  hemodynamic  response  to
tracheal  intubation,  with  results  similar  to  lidocaine.  We
conclude  that  the  used  doses  of  magnesium  sulfate  and
lidocaine  have  good  efﬁcacy  and  safety  for  hemodynamic
control  during  laryngoscopy  and  intubation,  presenting  as
an  option  to  mitigate  the  stimulation  of  upper  airway  in
patients  undergoing  general  anesthesia.Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
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